News

Pfizer Inc. and BioNTech SE announced plans to provide the U.S. government at a not-for-profit price 500 million doses of the companies’ COVID-19 vaccine, 200 million doses in 2021 and 300 million doses in the first half of 2022,...

Gamma Biosciences, a global life sciences company serving the advanced therapy market, announced the appointment of Terry Pizzie as Chief Executive Officer (CEO) of operating company Astrea Bioseparations.  Pizzie succeeds Dr. Steve Burton, who will remain with the company...

Q2 Solutions, a leading global clinical trial laboratory services organization and a wholly owned subsidiary of IQVIA, has announced the expansion of its laboratory and operational capabilities at its Alba Campus in Livingston, Scotland. This expansion of central labs,...

Q2 Solutions, a wholly-owned subsidiary of IQVIA and a leading clinical trial laboratory services organization, announced a transformative collaboration with Tasso Inc., a pioneer in clinical-grade, at-home, patient-centered blood testing, to develop diagnostic tests used in decentralized (virtual) clinical...

Scipher Medicine, a precision immunology company matching patients with the most effective therapy, in collaboration with Northeastern University; Brigham and Women’s Hospital, Harvard Medical School, and Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL), today announced they identified novel...

Belgium-based AARDEX Group, the world leader in medication adherence solutions, announced a strategic partnership with AdhereTech, an innovative company that improves the patient experience with real-time technology and Smart devices for optimal medication benefits. The collaboration will link AARDEX’s...

Following major growth, Genezen Laboratories Inc, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has announced the appointment of three board members: Iain Baird, Diana Caldwell and Tedd Green. The expansion of the team comes as Genezen...